Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-10 Purchase |
2025-02-27 6:42 pm |
Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
122,882 | $11.45 | $1,407,368 | 4,148,428 (Indirect) |
View |
| 2024-08-16 Purchase |
2024-08-20 2:23 pm |
ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner |
5,818 | $2.9334 | $17,067 | 2,117,213 (Indirect) |
View |
| 2024-07-24 Purchase |
2024-07-26 10:50 am |
ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner |
220,083 | $3.1768 | $699,165 | 2,111,395 (Indirect) |
View |
| 2024-07-03 Purchase |
2024-07-12 7:38 pm |
ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner |
408,777 | $3.4917 | $1,427,345 | 1,891,312 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-02-27 6:42 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
0 | $0 | 4,550,089 (Indirect) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:44 pm |
N/A 2035-01-21 |
Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance |
120,000 | $0 | 120,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:43 pm |
N/A 2035-01-21 |
Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer |
162,500 | $0 | 162,500 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:42 pm |
N/A 2035-01-21 |
Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel |
162,500 | $0 | 162,500 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:41 pm |
N/A 2035-01-21 |
Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto Chief Executive Officer |
230,000 | $0 | 230,000 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-21 6:30 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160,160 | $0 | 3,371,922 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160 | $23,000 | 3,212,082 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
275,000 | $23 | 3,212,082 (Indirect) |
View |
Ownership |
2024-09-06 5:07 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 19,662,752 (Indirect) |
View |
Ownership |
2024-09-06 5:07 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Turtle Cameron Director |
0 | $0 | 94,281 (Indirect) |
View |
Ownership |
2024-09-06 5:06 pm |
N/A 2034-03-22 |
Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director |
0 | $0 | 199,992 (Direct) |
View |
Ownership |
2024-09-06 5:05 pm |
N/A 2024-05-06 |
Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director |
0 | $0 | 94,282 (Direct) |
View |
Ownership |
2024-09-06 5:04 pm |
N/A 2034-05-06 |
Oruka Therapeutics Inc. | ORKA | BALL KRISTINE M Director |
0 | $0 | 94,282 (Direct) |
View |
Ownership |
2024-09-06 5:03 pm |
N/A 2034-05-06 |
Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel and Secretary |
0 | $0 | 328,559 (Direct) |
View |
Ownership |
2024-09-06 5:02 pm |
N/A 2034-05-06 |
Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer |
0 | $0 | 428,555 (Direct) |
View |
Ownership |
2024-09-06 5:01 pm |
N/A 2034-03-22 |
Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance and Treasurer |
0 | $0 | 214,277 (Direct) |
View |
Ownership |
2024-09-06 5:00 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto President and CEO |
0 | $0 | 2,480,851 (Direct) |
View |
| 2024-08-29 Other |
2024-08-30 5:57 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See footnote 1 |
24,000 | $0 | 0 (Direct) |
View |
Ownership |
2024-07-12 7:10 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner |
0 | $0 | 1,482,535 (Indirect) |
View |
| 2024-01-30 Option Award |
2024-01-31 6:39 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See footnote 1 10% Owner |
6,000 | $0 | 6,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Hove Anders D Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director |
6,000 | $0 | 6,611 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Flynn James P Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
6,000 | $0 | 56,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Grais Linda Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-01-31 4:25 pm |
N/A 2034-01-30 |
ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-19 5:33 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner |
1,420,000 | $2.5 | 4,048,452 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:33 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner |
6,000 | $0 | 4,048,452 (Direct) |
View |
| 2022-12-16 Expired |
2022-12-19 5:33 pm |
2022-12-16 2022-12-16 |
ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner |
300 | $0 | 4,048,452 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-19 5:33 pm |
2022-12-16 2022-12-16 |
ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner |
14,200 | $0 | 4,048,452 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:30 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:24 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director |
6,000 | $0 | 6,611 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:24 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | Grais Linda Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:23 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | Hove Anders D Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:20 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
6,000 | $0 | 56,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:19 pm |
N/A 2032-12-15 |
ARCA biopharma Inc. | ABIO | Flynn James P Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-12-08 Option Award |
2022-12-09 4:30 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer |
40,000 | $0 | 40,730 (Direct) |
View |
| 2022-12-08 Option Award |
2022-12-09 4:30 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-07-01 Other |
2022-07-08 7:17 pm |
2022-12-16 2022-12-16 |
ARCA biopharma Inc. | ABIO | Funicular Funds LP See Footnote 1 10% Owner |
2,609,452 | $0 | 11,771,808 (Indirect) |
View |